SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 396.31-0.6%Dec 31 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Haim R. Branisteanu who wrote (175718)8/10/2021 12:01:52 AM
From: TobagoJack  Read Replies (1) of 218886
 
Israel is going the next level up, and should third jab works out, fantastic. Should the third jab not work out, ‘they’ might try jab #4.

bloomberg.com

Pfizer Booster Causes Similar Side Effects to Second Dose: Study

Yaacov Benmeleh
August 9, 2021, 10:08 PM GMT+8
Most people who got a booster shot of the Pfizer Inc.-BioNTech SE Covid-19 vaccine had similar or fewer side effects than they did after the second dose, according to a preliminary study conducted by Israel’s largest health maintenance organization.

Of the 4,500 respondents to the survey, 88% reported “a similar or better feeling” than their reaction to the previous dose, with 31% saying they had localized effects like pain or swelling in the area of injection, according to a statement from Clalit Health Services late Sunday.

About 15% of people had other symptoms like tiredness, muscle aches or fever. Less than 1% reported difficulty breathing or chest pains.



A resident receives a third dose of the Pfizer vaccine in Tel Aviv, on Aug. 2.

Photographer: Kobi Wolf/Bloomberg

Israel became the first country in the world to disseminate booster shots widely in a bid to quell a surge in new cases. The U.S. hasn’t yet sanctioned the use of third doses, although Pfizer said it plans to meet with U.S. regulators for authorization. About 500,000 Israelis have received the third dose so far.

Fauci Says Covid Booster Shots May Go ‘Soon’ to Most Vulnerable

Clalit said the results of the study, involving people vaccinated over July 30 and Aug. 1, still needed to be analyzed carefully given the short testing period. Some people who received boosters may have been suffering from significant side effects that precluded their participation in the survey, it said.

BioNTech’s American depositary receipts climbed as much as 11% on Monday after the company raised its forecast for this year’s Covid-19 vaccine sales to 15.9 billion euros ($18.7 billion) and said it is pushing forward plans to test its messenger RNA technology in cancer.

(Updates to add BioNtech forecast and shares in last paragraph)

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE

Sent from my iPad
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext